Public Profile

Compugen Ltd.

Compugen Ltd., a leading biotechnology company headquartered in Israel (IL), has been at the forefront of immuno-oncology since its establishment in 1993. With a strong focus on discovering and developing innovative therapeutic solutions, Compugen operates primarily in the fields of cancer immunotherapy and autoimmune diseases. The company is renowned for its unique approach to drug discovery, leveraging proprietary computational biology platforms to identify novel targets and biomarkers. Compugen's core products include monoclonal antibodies and immune checkpoint inhibitors, which have shown promising results in clinical trials. With a robust pipeline and strategic partnerships, Compugen has positioned itself as a key player in the biotechnology sector, continually striving to advance patient care through cutting-edge research and development.

DitchCarbon Score

How does Compugen Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

18

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

2

Industry Benchmark

Compugen Ltd.'s score of 18 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.

84%

Compugen Ltd.'s reported carbon emissions

Compugen Ltd., headquartered in Israel (IL), currently does not have publicly available carbon emissions data or specific reduction targets. Without reported emissions figures, it is challenging to assess their carbon footprint or climate commitments. However, the company may still be engaged in sustainability initiatives or industry practices aimed at reducing environmental impact. As the landscape of corporate climate responsibility evolves, it is essential for companies like Compugen to establish measurable targets and transparent reporting to align with global climate goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Compugen Ltd.'s primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Compugen Ltd. is headquartered in IL, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Compugen Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

BioTissue Holdings Inc.

US
Research and development services (73)
Updated 5 days ago

American CryoStem Corporation

US
Health and social work services (85)
Updated 5 days ago

MiMedx Group, Inc.

US
Health and social work services (85)
Updated 5 days ago

Osiris Therapeutics, Inc.

US
Health and social work services (85)
Updated 5 days ago
DitchCarbon Score

TEI Biosciences Inc.

US
Medical, precision and optical instruments, watches and clocks (33)
Updated 5 days ago
DitchCarbon Score

Alliqua BioMedical, Inc.

US
Health and social work services (85)
Updated 5 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers